Quick Answer
Entera Bio Ltd. reported Total Assets of $15.99 million for the year ending 2025.
- Entera Bio Ltd. showed an increase of +70.3% in Total Assets from 2024 to 2025.
- This data is from Entera Bio Ltd.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: $22.31 million | Q2 2022: $19.09 million | Q3 2022: $15.54 million | Q1 2023: $11.61 million | Q2 2023: $10.45 million | Q3 2023: $8.57 million | Q1 2024: $10.24 million | Q2 2024: $10.04 million | Q3 2024: $7.74 million | Q1 2025: $21.60 million | Q2 2025: $19.67 million | Q3 2025: $17.41 million.
- Over the full 9 years of available data (2017 to 2025), Entera Bio Ltd.'s Total Assets has grown by 20.4%.
- Historical annual values: Fiscal year 2025: $15.99 million | Fiscal year 2024: $9.39 million | Fiscal year 2023: $11.77 million | Fiscal year 2022: $13.13 million | Fiscal year 2021: $25.99 million | Fiscal year 2020: $9.72 million | Fiscal year 2019: $16.70 million | Fiscal year 2018: $13.34 million | Fiscal year 2017: $13.28 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: